VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,212 | -88.8% | 235,927 | -70.6% | 0.00% | -100.0% |
| Q2 2023 | $19,674 | +118.5% | 802,034 | +107.3% | 0.00% | +200.0% |
| Q1 2023 | $9,005 | -7.7% | 386,945 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $9,761 | -99.9% | 385,648 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $7,436,000 | +65.4% | 385,609 | +118.4% | 0.00% | 0.0% |
| Q2 2022 | $4,496,000 | -61.2% | 176,539 | -60.8% | 0.00% | 0.0% |
| Q1 2022 | $11,583,000 | -53.7% | 450,363 | -24.6% | 0.00% | -50.0% |
| Q4 2021 | $25,015,000 | +1474.3% | 597,433 | +1536.0% | 0.00% | – |
| Q3 2021 | $1,589,000 | -55.7% | 36,519 | -51.9% | 0.00% | – |
| Q2 2021 | $3,586,000 | +12.8% | 75,853 | +22.4% | 0.00% | – |
| Q1 2021 | $3,178,000 | +81.4% | 61,979 | -5.3% | 0.00% | – |
| Q4 2020 | $1,752,000 | +93.0% | 65,416 | +147.3% | 0.00% | – |
| Q3 2020 | $908,000 | – | 26,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |